What are you claiming?

CoValence has recently seen the FDA pick up their pace at sending out Warning Letters to publicly traded and Indie brands in regards to a brand’s product claims that do not follow the FDA’s guidelines.

To help reduce a brand’s chances of receiving an FDA Warning Letter, we suggest that brands establish a regular review of their product claims to assure that their claims continue to be within the FDA guidelines (FDA.org).

Below, from the PCPC, are some examples of product claims that may or may not be challenged by the FDA: